IRCT2012071710313N1已完成未知
Efficacy of long-term Maintenance Therapy with Mycophenolate Mofetil in Lupus Nephritis
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Twenty four consecutive patients with the diagnosis of lupus in accordance with ACR classification criteria were enrolled. evidence of active proliferative glomerulonephritis in the renal biopsy (WHO class IV, III). In case of absent renal biopsy or the presence of WHO class V in biopsy, following clinical or paraclinical findings: proteinaria >1 gr/24 h (or sustained 2 to 4+ proteinuria); progressive renal failure with 30% decrease in creatinine clearance over one-year period and creatinine > 1.9 mg/dL; the presence of more than 5 red cells in HPF of urine sediment in two separate specimens taken in a year, presence of WBC, granular or hyaline casts without active infection
- •Exclusion criteria: WHO class I or II lupus nephritis; end stage renal disease when replacement renal therapy will be indicated, leukopenia (neutrophils < 1500/mm3) due to bone marrow suppression; recurrent episodes of bacterial infection; history of cytotoxic drug treatment for more than two weeks or pulse therapy with corticosteroids during a six-week period before study entry.
排除标准
- 未提供
研究者
相似试验
招募中
1 期
A phase I/II study of maintenance therapy with metformin and temozolomide for newly diagnosed glioblastoma patientsGlioblastomaJPRN-jRCTs031200326arita Yoshitaka22
招募中
不适用
Effects of long-term treatment with mineralocorticoid receptor antagonists on aldosterone synthesis in patients with primary aldosteronismPrimary aldosteronismJPRN-UMIN000010673Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan100
进行中（未招募）
1 期
A randomised trial to establish whether giving patients with advanced prostate cancer additional drug (orteronal) therapy immediately following chemotherapy will lengthen the time until their disease progresses and increase their quality of life in comparison to placebo.EUCTR2011-002965-39-GBSwiss Group for Clinical Cancer Research (SAKK)47
进行中（未招募）
1 期
Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)”.EUCTR2016-004322-42-Outside-EU/EEAovartis Pharma Services AG250
进行中（未招募）
不适用
Safety and Efficacy of long-term treatment with Echinaforce® over 4 months - Echinacea Safety Studycommon coldEUCTR2009-012297-12-GBBioforce AG750